Carol Chelimo1, Trecia A Wouldes. 1. Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
Abstract
AIMS: To describe knowledge of HPV and its transmission, knowledge of the HPV vaccine, and awareness of free HPV vaccine for 12-18 year old New Zealand females; and to assess whether there are significant age and gender differences in HPV-related knowledge. METHODS: Undergraduate university students were invited to complete an anonymous questionnaire, after viewing a brief HPV vaccine TV commercial. RESULTS: Compared to 19 year olds, 18 years olds were more likely to have heard of HPV (OR=3.78; 95%CI=1.66-8.65) and the HPV vaccine (OR=3.94; 95%CI=1.85-8.39), know about sexual transmission of HPV (OR=2.79; 95%CI=1.34-5.77), and be aware of the free HPV vaccine (OR=4.00; 95%CI=1.81-8.84). Participants who knew someone ever diagnosed with cervical cancer were more likely to have heard of the HPV vaccine (OR=2.98; 95%CI=1.09-8.13). Male participants were less likely to be aware of the free vaccine (OR=0.16; 95%CI=0.07-0.40). CONCLUSION: Average levels of basic knowledge of HPV and HPV vaccine most likely represent minimal awareness as more specific knowledge on sexual transmission of HPV is low. HPV vaccination should be complimented with public education on the link between sexual behaviour, HPV infection and cervical cancer.
AIMS: To describe knowledge of HPV and its transmission, knowledge of the HPV vaccine, and awareness of free HPV vaccine for 12-18 year old New Zealand females; and to assess whether there are significant age and gender differences in HPV-related knowledge. METHODS: Undergraduate university students were invited to complete an anonymous questionnaire, after viewing a brief HPV vaccine TV commercial. RESULTS: Compared to 19 year olds, 18 years olds were more likely to have heard of HPV (OR=3.78; 95%CI=1.66-8.65) and the HPV vaccine (OR=3.94; 95%CI=1.85-8.39), know about sexual transmission of HPV (OR=2.79; 95%CI=1.34-5.77), and be aware of the free HPV vaccine (OR=4.00; 95%CI=1.81-8.84). Participants who knew someone ever diagnosed with cervical cancer were more likely to have heard of the HPV vaccine (OR=2.98; 95%CI=1.09-8.13). Male participants were less likely to be aware of the free vaccine (OR=0.16; 95%CI=0.07-0.40). CONCLUSION: Average levels of basic knowledge of HPV and HPV vaccine most likely represent minimal awareness as more specific knowledge on sexual transmission of HPV is low. HPV vaccination should be complimented with public education on the link between sexual behaviour, HPV infection and cervical cancer.